Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)

  • Early Phase (Preclinical - Phase 2)
  • Late Phase (Phase 2 onwards)


*Denotes required.


From Lab to Launch: Successful Drug Development Strategies Using Lipid-based Formulations and Softgels

This event is now available on demand.

Event Overview:

Lipid-based formulations (LBFs) and softgel capsules have been shown to improve the bioavailability of poorly soluble drugs while providing a fast and cost-effective path to the clinic and market. However, fully unlocking the potential of this dosage form requires a holistic approach that seamlessly integrates formulation development and soft gel manufacturing. This webinar aims to simplify these complex scientific concepts and shed light on the nuances of LBF and softgels. Experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.

Key learning Objectives:
  • Gain insights into the benefits of LBFs and softgels in addressing the challenges of delivering poorly soluble drugs.
  • Understand how to select appropriate excipients and optimize LBFs.
  • Discover how an integrated approach can accelerate LBF candidate development and ensure successful translation into clinical products.

Who Should Attend:
  • Chief Scientific Officer (CSO)
  • Chief Medical Officer (CMO)
  • Senior Vice President (SVP), VPs, or Directors
  • Senior Manager or Manager
  • Formulation Scientist
Job Function:
  • Research and Development (R&D)
  • Product Development
  • Chemistry, Manufacturing, and Control (CMC)
  • Preclinical Development
  • Clinical Development
  • Biopharma Industry Consultants

Featured Speakers


René Holm, PhD
René Holm, PhD
Professor of Pharmacy
University of Southern Denmark

Dr. René Holm is a pharmaceutical expert who received his PhD at the University of Copenhagen in 1998 and 2002. He joined Lundbeck in 2001 and moved to Janssen in 2016. Dr Holm worked in various fields such as physical chemistry, material science, and pharmaceutical development. He has co-authored more than 200 original articles and is currently a professor in pharmaceutical physical chemistry at the University of Southern Denmark.


Speaker's Email: reho@sdu.dk
Speaker's Linkedin: René Holm 


Guillaume Enderlin, PharmD
Guillaume Enderlin, PharmD
Senior Manager of Pharmaceutical Development Catalent Beinheim
Catalent Pharma Solutions

Dr. Guillaume Enderlin is senior manager of pharmaceutical development at the Catalent Beinheim site in France. He worked for 12 years in softgel R&D, from formulation to manufacturing and development processes, building expertise to cover the whole Rx Pharmaceutical Development process. Guillaume is a pharmacist and has a master’s degree in pharmaceutical engineering.

Speaker's Email: guillaume.enderlin@catalent.com
Speaker's LinkedIn: Guillaume Enderlin 




For any technical questions please contact Jordan Ramesh:
Jramesh@mjhlifesciences.com